BioSpace News Archive

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the first quarter 2022, after the market close on Wednesday, April 27, 2022.

Personalis, Inc., a leader in advanced genomics for cancer, announced that it will release its first quarter 2022 financial results on Wednesday, May 4, 2022.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 10, 2022, at 4:30 p.m. ET to discuss its financial results for the fiscal 2022 second quarter ended March 31, 2022.

GENFIT announced that it published in the April 20, 2022 French legal announcements bulletin n°47 its convening notice that the Combined Shareholders Meeting will be held on May 25, 2022, at 10:00am, at the Faculty of Pharmaceutical Sciences in Lille, located at Parc Eurasanté, 3 rue du Professeur Laguesse, 59000 Lille, France.

Bluejay Diagnostics, Inc. today announced financial results for the quarter ended March 31, 2022.

Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report results for its first quarter 2022 ended April 3, 2022, after the market close on Wednesday, May 4, 2022.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter results on Wednesday, May 4, 2022, after the close of the market.

Quest Diagnostics today announced it has made several organizational changes and leadership appointments of seasoned executives to better support the company’s two-point business strategy to accelerate growth and drive operational excellence.

Jazz Pharmaceuticals plc today announced that it will report its 2022 first quarter financial results on Wednesday, May 4, 2022, after the close of the U.S. financial markets.

Outset Medical, Inc. today announced that it will release financial results for the first quarter of 2022 after the close of trading on Wednesday, May 4, 2022.